PL369754A1 - Liofilizowany preparat zawierający immunocytokiny - Google Patents

Liofilizowany preparat zawierający immunocytokiny

Info

Publication number
PL369754A1
PL369754A1 PL03369754A PL36975403A PL369754A1 PL 369754 A1 PL369754 A1 PL 369754A1 PL 03369754 A PL03369754 A PL 03369754A PL 36975403 A PL36975403 A PL 36975403A PL 369754 A1 PL369754 A1 PL 369754A1
Authority
PL
Poland
Prior art keywords
immunocytokine
lyophilized preparation
containing lyophilized
preparation
reconstitution
Prior art date
Application number
PL03369754A
Other languages
English (en)
Inventor
Hans-Peter Zobel
Sven Oliver Arndt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL369754A1 publication Critical patent/PL369754A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL03369754A 2002-02-06 2003-01-14 Liofilizowany preparat zawierający immunocytokiny PL369754A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10204792A DE10204792A1 (de) 2002-02-06 2002-02-06 Lyophilisierte Zubereitung enthaltend Immuncytokine

Publications (1)

Publication Number Publication Date
PL369754A1 true PL369754A1 (pl) 2005-05-02

Family

ID=27588393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03369754A PL369754A1 (pl) 2002-02-06 2003-01-14 Liofilizowany preparat zawierający immunocytokiny

Country Status (17)

Country Link
US (1) US20050220758A1 (pl)
EP (1) EP1471942A1 (pl)
JP (1) JP4422485B2 (pl)
KR (1) KR20040091015A (pl)
CN (1) CN1627958A (pl)
AR (1) AR038355A1 (pl)
AU (1) AU2003244470B2 (pl)
BR (1) BR0307448A (pl)
CA (1) CA2475211A1 (pl)
DE (1) DE10204792A1 (pl)
MX (1) MXPA04007562A (pl)
PE (1) PE20030898A1 (pl)
PL (1) PL369754A1 (pl)
RU (1) RU2316348C2 (pl)
TW (1) TW200303756A (pl)
WO (1) WO2003066102A1 (pl)
ZA (1) ZA200407028B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9770517B2 (en) 2002-03-01 2017-09-26 Immunomedics, Inc. Anti-Trop-2 antibody-drug conjugates and uses thereof
JP2006045162A (ja) * 2004-08-06 2006-02-16 Takeda Chem Ind Ltd 注射用ペプチド含有組成物
CA2576519C (en) * 2004-08-17 2013-05-21 Regeneron Pharmaceuticals, Inc. Il-1 antagonist formulations
EP1930006A4 (en) * 2005-09-28 2010-10-13 Daiichi Sankyo Co Ltd METHOD FOR PRODUCING A CHINOLONE-CONTAINING LYOPHILIZED PREPARATION
US8476239B2 (en) 2005-12-20 2013-07-02 Bristol-Myers Squibb Company Stable protein formulations
US9309316B2 (en) 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
DE102007050165B4 (de) * 2007-10-19 2010-06-17 Stiftung Tierärztliche Hochschule Hannover Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung
ES2525257T3 (es) * 2009-02-25 2014-12-19 Supratek Pharma, Inc. Composiciones de ciclopolisacárido y de bendamustina
TWI527590B (zh) * 2011-06-17 2016-04-01 艾瑞斯貿易公司 Ｆｇｆ－１８之凍乾調配物
US9382329B2 (en) 2012-08-14 2016-07-05 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to Trop-2 expressing cells
WO2015047510A1 (en) * 2013-09-27 2015-04-02 Immunomedics, Inc. Anti-trop-2 antibody-drug conjugates and uses thereof
CN106456695B (zh) 2014-04-28 2019-11-12 卫材R&D管理有限公司 Hgf的冻干配制品
KR102275262B1 (ko) 2016-03-17 2021-07-12 에자이 알앤드디 매니지먼트 가부시키가이샤 활성 간세포 성장 인자(hgf)를 생성하는 방법
CN116327966A (zh) * 2021-12-24 2023-06-27 广州达安基因股份有限公司 冻干保护剂、il-6冻干粉剂及其制备方法
CN114224853B (zh) * 2022-01-04 2022-09-23 山东新时代药业有限公司 聚乙二醇化重组人粒细胞刺激因子注射用冻干制剂
CN114515334B (zh) * 2022-02-22 2024-02-20 史辛艺 一种脂肪间充质干细胞因子冻干粉及其制备方法
JPWO2025013783A1 (pl) * 2023-07-07 2025-01-16

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150067A3 (en) * 1984-01-23 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
JPS61197527A (ja) * 1985-02-25 1986-09-01 Takeda Chem Ind Ltd インタ−ロイキン−２組成物
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
WO1989010756A1 (fr) * 1988-05-06 1989-11-16 Toray Industries, Inc. COMPOSITION D'INTERFERON beta STABLE
US5104651A (en) * 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
EP0689843B1 (en) * 1993-12-17 2003-09-10 Mochida Pharmaceutical Co., Ltd. Composition containing soluble thrombomodulins
JP3822383B2 (ja) * 1993-12-17 2006-09-20 持田製薬株式会社 可溶性トロンボモジュリン含有組成物
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
TW497972B (en) * 1995-06-08 2002-08-11 Kirin Brewery Stable thrombopoietin (TPO)-containing lyophilized compositions
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
RU2129878C1 (ru) * 1996-04-24 1999-05-10 Зинченко Елена Вениаминовна Иммуномодулирующий препарат с противовирусной активностью "неоферон"
EP0852951A1 (de) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern

Also Published As

Publication number Publication date
JP4422485B2 (ja) 2010-02-24
BR0307448A (pt) 2004-12-28
CA2475211A1 (en) 2003-08-14
EP1471942A1 (de) 2004-11-03
RU2004126942A (ru) 2005-06-10
KR20040091015A (ko) 2004-10-27
AR038355A1 (es) 2005-01-12
US20050220758A1 (en) 2005-10-06
AU2003244470B2 (en) 2008-03-13
PE20030898A1 (es) 2003-10-25
TW200303756A (en) 2003-09-16
ZA200407028B (en) 2006-02-22
DE10204792A1 (de) 2003-08-14
MXPA04007562A (es) 2004-11-10
RU2316348C2 (ru) 2008-02-10
AU2003244470A1 (en) 2003-09-02
WO2003066102A1 (de) 2003-08-14
CN1627958A (zh) 2005-06-15
JP2005516998A (ja) 2005-06-09

Similar Documents

Publication Publication Date Title
PL369754A1 (pl) Liofilizowany preparat zawierający immunocytokiny
MX2010009850A (es) Analogos de insulina acilados y etabilizados contra proteasas.
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
BE2013C064I2 (pl)
ZA200407794B (en) Novel biomaterials, their preparation and use.
EP2316479A3 (en) Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
EP2275125A3 (en) Protein-based streptococcus pneumoniae vaccines
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
MXPA03008310A (es) Interferon beta modificado con inmunogenicidad reducida.
MX2008004734A (es) Composicion rica en leucina.
PL1609481T3 (pl) Nadająca się do wstrzykiwania kompozycja farmaceutyczna zawierająca diklofenak sodowy, beta-cyklodekstrynę i polisorbat
EP1549346A4 (en) MODIFIED RECOMBINANT CELLS (ARCS) FOR THE PRODUCTION AND DISTRIBUTION OF ANTIVIRAL AGENTS, ADJUVANTIES AND VACCINE ACCELERATORS
EP1682565A4 (en) IAP NUCLEOBASE OLIGOMERS AND OLIGOMERE COMPLEXES AND APPLICATIONS THEREOF
AR061352A1 (es) El uso de timosina alfa 1 para preparar un medicamento destinado al tratamiento del melanoma maligno de estadio iv
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
AU2001230195A1 (en) Pharmaceutical compositions comprising terbinafine
NZ528544A (en) Formulations comprising entrapped active ingredients and uses thereof
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
PL373549A1 (pl) Dodatek do żywności jak również środek uzupełniający do żywności i leków
GB0201717D0 (en) Needleless injector
AU2002342949A1 (en) Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)